Differences in Health-Related Quality of Life Predictors in People Living With HIV With and Without Diabetes.
Julie Ann Zuñiga, Dong Eun Jang, Gregory Walker and 2 others
PMID 31789685WHAT IT FOUND
Depression and anxiety predicted poor quality of life in people with HIV and diabetes.
Unlike those with HIV alone, physical activity, medication adherence, and smoking status did not predict quality of life in the dual-diagnosis group.
Key findings
01In patients with both HIV and diabetes, only lower depression scores and lower anxiety scores significantly predicted better health-related quality of life.
02In patients with HIV alone, six variables predicted better quality of life: lower depression, better medication adherence, regular physical activity, younger age, lower anxiety, and never smoking.
03Patients with both HIV and diabetes had significantly lower physical activity levels and lower health-related quality of life compared to those with HIV alone.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study excluded patients with missing data, which may have underestimated the impact of variables. Data were collected for clinical care, not research, so measures like physical activity and medication adherence may not be precise. The study did not capture adherence to diabetes medications, which could influence quality of life in the dual-diagnosis group. Differences between groups could be due to age, diabetes, or both, as the study lacked a diabetes-only comparison group.
Declared interests
The authors report no real or perceived vested interests related to this article.
The easy way to misread this
Do not conclude that physical activity and medication adherence are unimportant for patients with HIV and diabetes. They did not predict quality of life in this specific analysis, but they remain clinically vital for disease management and may have other benefits not captured by the HRQoL measure used.